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: -ABSTRACT

, The objective of this: study is to- evaluate the :



impact, of the Diabetes Nurse Care Manager on an at-risk
diabetic population using a Primary Care Group Visit
Model.in Outlying Medical.Offices within the

Kaiser-Permanente Health Care::S

upon the process and

outcome , of care- in this, pppulatidn,.

This study was 'pefformed in the primary Care Clinics

of a large group-model Health Maintenance Organization ,
, ,(HMO:) in Southern California. Poorly controlled diabetic :
members > 30.years of age were selected for a nurse. ,

management intervention .based upon elevated .Hemoglobin
Ale (HbAlc) values of. 8.9% and higher,- These patients
attended least one nurse managed group visit appointment
in their Local Medical Office with their Primary Care

Physician acting as a figure of authority. Tjie Care

Management - nurse-, subsequently .followed each individual

patient by phone in order to improve patient, adherence to
Clinical Practice Recommendations..

In a three and six month analysis, the intervention

group had significantly improved its Outcome Parameters
for Quality of Care. HbAlc, which is a clinical marker
for diabetes control, improved by 23.9% in three, months

ill

and improved by 27.8% in six months. Surrogate Parameters

for long-term Quality Measures,such as Urinary
Microalbumin, LDL-Cholesterol, and Retinal Screening
Examinations also improved.

A Primary Care Group Visit Model that utilized.a
Diabetes Nurse Care Manager in a shared-practice
situation with the Primary Care Doctor in the Outlying
Medical Offices has demonstrated improved Quality of Care
delivered to at-risk diabetic patients.
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CHAPTER ONE

PROPOSAL

Introduction

Diabetes is a chronic, sometimes debilitating,

disease. Based upon research reported in the Diabetes

Control and Complications Trial [DCCT] (1993) as well as
the UK Prospective Diabetes Study [UKPDS] (1998),
improved diabetic control of blood sugars , has helped
decrease the incidence of certain long-term

complications. The monitoring of yearly retinal screening
examinations. Hemoglobin Ale (HbAlc), Urinary
Microalbumin (MA), and Low-Density-Lipoprotein (LDL)
Cholesterol all contribute to improved clinical outcomes.

Greenfield, Rogers, Mangotich, Carney, and Tarlov (1995),

McCullough, Price, Hindmarsh and Wagner (1998), and many
others, have shown that any method that improves

compliance with routine monitoring and treatment will
translate into improved health status for the patient.
Recently, Martin, Selby, and Zhang (1995) and Ho,
Marger, Heart, Yip, and Shekelle (1998) have shown that
most health-care organizations approach the challenges of
monitoring and screening for diabetes complications in a

haphazard manner. The implementation of computerized
databases used to manage large numbers of people with
chronic conditions is still in its infancy. According to

Frame (1995) there are no set standards for their usage.

The point is well made by Ornstein, Garr, Jenkins,
Musham, Hamadeh, and Lancaster, (1995) that the majority

of these Computerized Decision Support Systems (CDSS) are

compartmentalized in large, centralized Diabetes Care

Specialty Clinics. Paradoxically, it is the Primary Care
Practitioner that reguires this data tool to help manage

the relatively well-controlled diabetic patient before
he/she becomes a high-risk diabetic patient.

Wagner (1998) concluded that the role of Diabetes
Nurse Educators and Diabetes, Nurse Care Managers is a
field in evolution. The Nursing Scope of Practice (2000),

which allows a Registered Nurse the capacity to monitor

and modify treatment regimens on an individual basis, has
undergone a great metamorphosis in recent years. These

highly trained professionals must constantly use their
skills for assessing compliance, determining the degree
of diabetes control, and changing treatment parameters in

the course of managing those patients under their care.

The research of Aubert et al. (1998) and others has

demonstrated that Diabetes Nurse Care Managers have

proven to be the best resources for following diabetic

patients through the use of large computerized databases.
Their skills include Case Finding the optimal population
to be followed, contacting the Primary Care Physician

(PCP) and diabetic patient in order to initiate Case

Management, and performing the. actual psychoeducational
and management interventions during the course of
treatment.

The presence of computerized Clinical Patient

Registries such as those evaluated in the study by Shea,
Du Mouchel, and Bahamonde (1996), in addition to detailed
Clinical Practice Guidelines (CPG), and precise Policies
and Procedures (P&P) for delivering diabetes care have

provided the ideal manner for improving the quality of
diabetic care in the managed-care environment. The

combination of these tools together with Computerized
Decision Support Systems and a functioning Electronic
Health Record (ERR) as documented by Baker, Lafata, Ward,
Whitehouse, and Divine, (2001) have vastly improved our.

proactive approach to diabetes care. Batalden et al.,
(1997) have demonstrated that the data generated from

these electronic databases should form the basis of a

Continual Quality Improvement approach to managing a

large group of diabetic patients. The national
organizations responsible for monitoring the quality of
care within large healthcare systems, such as the
National Committee for Quality Assurance (NCQA), have

begun to require the measurement of such data and the
creation of systems for maintaining and improving the
quality of care being delivered.

Statement of the Problem

As Physicians become more and more overworked, their
time spent per patient goes down. Physicians are unable
to fully-educate their diabetic patients, and therefore
have delegated this duty to the Diabetes Nurse Educator.
The Diabetes Educator, as described in the work of

Peters, Davidson, and Ossorio (1995), has become a

Physician Extender in the sense of monitoring laboratory
results and ordering routine lab testing for the

specialty clinics supporting the work of the Primary Care
Provider. However, the full use of Diabetes Nurse

Educators in the Outlying Medical Offices was never
realized in the past due to resource and staffing

limitations within the Fontana Diabetes Care Clinic.

Primary Care Physicians are now becoming even more
interested in improving care and outcomes in their
diabetic populations. The British studies by Pringle,
Ward, and Chilvers (1993), Farmer and Coulter (1990), and

Koperski (1992) show that the development of the
"mini-clinic" is a movement toward providing much more

than routine care in Outlying Medical Offices.
In following the Clinical Practice Recommendations
(2001) of the American Diabetes Association (ADA), we

find that routine care for persons with diabetes should

consist of yearly monitoring of Hemoglobin Ale, Urinary
Microalbumin, Low-Density-Lipoprotein Cholesterol, and

Retinal Screening Examinations. In addition, there should
be feedback of pertinent information to the patient in

order to initiate any necessary changes in diabetes
treatment. This is usually followed up with an assessment

of the patient's response to the new treatment and the
need for further treatment. However, the work of Khoury,

Churgin, and Strawn, (1998) demonstrates .that Physician

compliance with the many Clinical Practice Guidelines.
(CPG) that they are required to be familiar with has been

diminishing due to lack of available time and. the

proliferation of multiple new guidelines. Physicians are
increasingly unable to provide this care on their own and
within a reasonable amount of time.

Diabetes Nurse Care Managers are individuals that

have, in the past, provided basic educational
interventions, individual consultations, and formalized

medication management in a highly structured and

centralized hospital clinic environment. Their role is

changing as the population of people with diabetes within
any given healthcare organization becomes better defined.
Wagner, Austin, and Von Korff, (1996) again has shown
that the higher-risk patients need more direct care.

Those patients in most need of care are often those who
do not keep their appointments in a standard clinic
setting. Therefore, changing the venue in which the care
is delivered back to the Primary. Physician's office has

become a useful adjunctive treatment to routine diabetes
care. However, no one has determined the impact of this

intervention on the overall quality of care delivered to

a higher-risk diabetic population.

Need for the Study

This study has been designed to assess the

effectiveness and impact of allocating Diabetes Nurse
Care Managers to Outlying Medical Offices of the
Kaiser-Permanente Health Plan in the Fontana Service

Area. This study has helped to determine whether the
allocation of Clinical Nurse Educator resources to the

outlying clinics improves the parameters associated with
good quality diabetes care. There is still a need for

subsequent research upon potential savings, benefits,
limitations, and trade-offs associated with this change
in resource allocation. In addition, this model of care

must directly or indirectly benefit the Physicians in the
medical offices in which the care is delivered.

Furthermore, in order to continue this model of care,
there must be an assessment of satisfaction of the

patients, since profound patient dissatisfaction would
hinder long-term compliance with the requirements
mandated for quality patient care.

Regulatory agencies such as the National Committee
for Quality Assurance have begun to require studies of
impact and quality of care when assessing the .
effectiveness of large managed healthcare agencies with
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defined patient populations. This study helps meet the
needs of these agencies as well as the needs of the

Department of Preventive Medicine in which these Diabetes
Nurse Care Managers function. Additionally, this
information has permitted the Department of Preventive
Medicine to demonstrate value to the Medical Group
Administrative Team in Fontana.

Scope and Limitations
This study has been conducted entirely with members

of the Kaiser Health Plan that are managed by the
Southern California Permanente Medical Group (SCPMG).
There are over 3 million lives covered by the

Kaiser-Permanente Health Care System in Southern
California. In the Fontana Medical Service Area there are

approximately 371,000 active members. Of this number
there are 15,482 individuals (4.2 percent) identified as

having Diabetes Mellitus. A nonrandomized longitudinal

study was conducted on a subset of this population being
followed in the Outlying Medical Offices of Colton and
Victorville in the Fontana Medical Service Area. All

participants were over 18 years of age and had been

Kaiser Health Plan members continuously for the one year

preceding enrollment In this study.
The patients being studied had been chosen only for
those Physicians that wished to participate In a
shared-practice group visit model of care In which a
Diabetes Nurse Care Manager helped that Physician manage

a higher-risk subset of his/her diabetic patients. There
Is Insufficient evidence to note whether cooperative

physicians have better or worse outcomes with their
diabetic patients. Therefore, this population must be
considered to be a nonrandomlzed sample.

In addition, the choice of selecting a range of

Hemoglobin Ale from 9.0 and above to represent a

higher-risk group was arbitrarily based upon the Health
Plan Employer Data and Information Set (HEDIS, 2000)
measures demonstrating poor vs. acceptable control for
diabetic Health Plan members whose Hemoglobin Ale was

at-rlsk of exceeding the threshold value of 9.5%.

The patients that participated In this
shared-practice model had agreed to come to one physician
visit during which the Diabetes Nurse Care Manager

explained his/her role and limitations. He/she also
discussed general Diabetes Care Guidelines with the

participating members. This could lead to some degree of
bias towards ambulatory patients or patients with

available transportation. The work of Wagner et al.,
(2001) at the Group Health Cooperative of Puget Sound

demonstrated that patients with good family or community
resources tend to do better in their diabetes care than

do those patients who do not have these resources.
In the course of this dissertation, the issues of

patient compliance, general authority figures as well as
time and place utility have been discussed in the context
of the study layout. Discussion of group dynamics and
educational interventions also plays a significant part

in describing the full impact of this study. The

importance of Provider - Patient communication and timely
feedback of results also plays an important role in the
final discussion.

Sampling Plan

The population for this study was defined through a
Care Management tool (POINT) developed by Pharmacy

Analytic Systems within Kaiser-Permanente. This database

system allowed queries to be undertaken on the Southern
California Region-wide Diabetes Registry. The Medical
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Center's and the individual Physician's diabetes panel
was easily identified using this tool. A list of those

patients with a Hemoglobin Ale greater than 8.9% were
presented to their Primary Care Physician for approval.

If approved, these patients were then contacted by phone
and/or letter asking them to participate in a two-hour
doctor's visit in which several individuals would address

their diabetes management. It is at this point that some
individuals were excluded by refusal, educational

barrier, or language barrier. These individuals were then
offered one-to-one counseling and management by a

culturally appropriate Physician or Nurse Educator.
When the group of selected members met with the
Diabetes Nurse Care Manager and their Primary Physician,

they received an educational intervention, followed by a
review of their medical treatment and pertinent

laboratory testing. Those patients that needed any
changes in medication got those changes made on the spot.
Pertinent laboratory tests were ordered and performed the

same day. The Diabetes Nurse Care Manager was responsible
for informing his/her patients of the results of their
tests and maintaining phone and letter contact with
his/her patient population for at least one-year.
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However, for the purpose of this study, each patient

population was studied for six months prior to their
intervention as well as six months after their
intervention.

The data collected on each patient by each nurse at

every intervention was recorded in a clinical diabetes
database that served as an Electronic Health Record

(EHR). Further data for this study were available on

legacy mainframe computers that compiled administrative
data, as well as demographic, , laboratory, pharmacy, and

hospitalization data for the members of the Kaiser Health
Plan.

Methods and Procedures

The population already discussed had been followed
for improvement in their surrogate care parameters

(Frequency of performing HbAlc, MA, and LDL-Cholesterol)
as a measure of their quality of care. During the course
of the study any changes in these parameters have been
attributed to the Nurse Care Manager intervention as

these patients were receiving routine care prior to their
intervention. In addition, all participants had been

continuously enrolled in the Kaiser Health Plan for the
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one-year preceding this study.thus allowing direct
comparisons to take place within each group.
In order to demonstrate statistically significant

changes in Hemoglobin. Ale frequency. Urinary Microalbumin
frequency, LDL-Cholesterol frequency, as well as changes
in HbAlc values;, an Average Frequency, Analysis of

Variance (ANOVA), and/or t-test has been calculated for

each parameter. To control for the patient's expected
likelihood of receiving the routine care and screening

tests, these patients have been compared to their own
previous lab values prior to the Care Management
intervention.

Additional data was collected on the frequency of

performing yearly Diabetic Retinal Screening
Examinations. This data was compared to regional averages
within the Kaiser-Permanente Health Care system as well

as to national averages for other health care plans. That
data is available through the National Committee for

Quality Assurance (HEDIS, 2000).
Data on the presence of abnormal urinary
Microalbumin and abnormal LDL-Cholesterol were obtained

through the POINT Care Management tool. This data tool
also provided information on whether each patient had
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received pharmaceutical treatment for his or her clinical
laboratory abnormality. That data was also compared with
National and Regional averaged data.

Brief Summary

This study was designed to help answer the question
on whether allocating Diabetes Nurse Care Managers to

outlying Medical Offices is effective in improving care
to diabetic members of Kaiser Permanente by evaluating

the frequency of testing Hemoglobin Ale, Urinary
Microalbumin, and LDL-Cholesterol for a six month period

before and a six month period after initiation of
Diabetes Care Management in outlying Medical Offices. The

Hemoglobin Ale value has also been used to help assess
the degree of improvement in diabetes control during the
course of this study. This study also helps determine
whether Diabetes Nurse Educator resources shall continue

to be allocated to Outlying Medical Offices and whether
this model of care should be expanded in the future. The

business case for expansion will be presented to the
administrative team at the Fontana Kaiser-Permanente

Medical Center.
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CHAPTER TWO

REVIEW

OF THE

LITERATURE

' Historical Background
Since this study is based upon the evaluation or a
new method of care delivery within the Department of
Preventive Medicine at the Kaiser Permanente Medical

Center in Fontana, California, it is obligatory to look
at what has come before in order to fully understand the

impact of the ongoing process of change.
In the past. Preventive Medicine has been the

department that provided health education and training to
people with identified disease processes and disease
risks in order to modify behavior toward a more healthful

lifestyle. This function was provided by Health .
Educators, nurses, dieticians, and behavioral specialists

who used commonly available educational tools, such as
classroom instruction, individual instruction, books,

pamphlets, and handouts. These goals were defined by
getting the greatest number of identified people to
classes. The greatest problem that arose with the
traditional educational function of Preventive Medicine

was that there were no measurable clinical outcomes (just
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educational outcomes), and that the people with the most

need for any intervention were almost always the ones who
never came to the classes. Over time, other health plans

scaled back their Preventive Medicine Departments to
reflect a subordinate role in the health care system. In
discussion with others, I have learned that Preventive

Medicine Departments frequently consisted of a single

person who coordinated classes and mailings. The lack of
a consistent business case hurt the development and

growth of Preventive Medicine in the past. The lack of
defined populations of people with a disease or disease
risk posed another great obstacle to the development of
modern Preventive Medicine. It was the growing use of
Information Technology that helped bring the science of
Preventive Medicine to the forefront of medical science.

Dr Eric Ngo began the Preventive Medicine Department
at the Kaiser Permanente Medical Center in Fontana,

California in 1976. He had the support of Kaiser Health

Plan as well as the Medical Group Administration to place

the multiple functions of Preventive Medicine beneath one
roof. This served to coordinate and integrate the

delivery of Preventive care as well as allow innovation
in the design of preventive care programs. Dr Ngo hired
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nurses and educators with good,clinical backgrounds since

they would have an existing store of knowledge to share
with our at-risk patient population. These core
individuals became the innovators of new models of

preventive care delivery.
The nurses and physicians in Preventive Medicine

forever changed the diabetes program. In 1979, Marli
Crane RN, MFT had attended a lecture by Dr. Mayer
Davidson describing a concept of using Registered Nurses
to advise patients on how to use their diabetic

medications properly. This involved changing insulin
dosages based upon an algorithm prescribed by a treating

physician. This Model of Care, which Davidson et al.,
(1998) described in subsequent papers, placed more
responsibility upon the nurse and actively included nurse
educators in the treatment portion of care. Over time,

these nurses developed the skills involved for using most
of the medications needed in diabetes management.

Algorithms on standing orders enabled a much greater

participation by the Nurse Educator in the practical care
of our diabetic patients.
The traditional concept of Preventive Medicine was
extended to its logical limits within the next eight
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years. In 1987,. a comprehensive treatment team was formed
to treat diabetes and its many complications. An MD

Endocrinologist was hired to improve the health of all
diabetic Kaiser Health Plan members. This meant that the
role of Preventive Medicine would have to be extended to

outreach to all people affected by diabetes, A means of
identifying those people affected by diabetes had yet to
be developed. However, planning was begun to convert a

system of paper charting to an electronic record of all
diabetic members. This would at least create a list of

people identified with diabetes who have been referred to
the Preventive Medicine Department. This would form the

core of what would become a complete registry of all
Kaiser Health Plan members with diabetes in the Fontana
Service Area.

The Fontana Diabetes Team in 1987 consisted of one

(1) MD Endocrinologist, five (5) Diabetes Nurse

Specialists that obtained Certified Diabetes Educator
(ODE) credentials, one (1) Registered Dietitian (RD) who
obtained ODE certification, and the staff of Preventive

Medicine for program support (one (1) MD Chief of

Department, one (1) Department Administrator (DA), three
(3) PHD Doctors of Health Science, three (3) Registered
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Dietitians, three (3) Certified Health Educators, and

their clerical support). During this period of time,
diabetes care was expanded into perinatal care, which

includes gestational and pre-gestational diabetes care.
The team became capable of handling complex cases,

including people on insulin pumps. However, the major
change was focus on diabetic complications rather than
glucose numbers and glucose control. This shift in
emphasis meant that more resources would be needed to
identify at-risk individuals and target specific
treatments. In 1989, Dr Gary Wong became a member of the

Department of Preventive Medicine. His background with a
Masters in Public Health gave the department the skills
needed to actually create a patient tracking system for

diabetes. The greatest difficulty in creating such a

system was to create the database structure to store the

information needed to identify and follow this patient
population. Meetings between Dr Wong and the
Endocrinologist, Dr. Edward Hess, resulted in a
clinically useful tool for managing an identified
diabetic population. The missing step was to identify
diabetic members who had not been referred to the

Preventive Medicine Department. This relational database
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had many features that allowed improved patient
identification and tracking. Laboratory data was
downloaded into the database to allow tracking of
critical valves for diabetes management. Communication

between the patient and the department improved with the
use of a letter generation function.
Between 1993 and 1995, a similar system was created

on a region-wide scale. A Diabetes Registry was generated
from laboratory

pharmacy, hospital, and emergency

department data. This was to be used to provide
compliance data for national quality standards data
collection. That system has evolved into a regional

repository of diabetes data that allows a comparison
within a Medical Service Area as well as between Medical

Service Areas, as well as between various Health Plans.
From 1995 onward, other Medical Centers within the
Southern California Permanente Medical Group had

developed patient tracking systems. Most of these systems
also had means of tracking changes in laboratory values

and clinical complications. The major differences were in
the manner in which this.data was used to improve patient

care, and the allocation of resources required to provide
that care within each Medical Service Area.
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From 1995 to 2000, the role of the Diabetes Nurse

Specialist had shifted slowly toward becoming a Care
Manager. The nurse had become a vital partner in the

ongoing care of people with chronic conditions. The
algorithms for changing insulin dosages had expanded to
full Policies and Procedures that helped identify people
at-risk for stroke, heart attacks, or renal failure.

Assisting people in obtaining proper treatment for

diabetic complications permitted earlier diagnosis and
treatment. This treatment is essential in preventing

progression of serious complications. The focus on
Population Care Management (PCM) required that nurses
become aware of other co-morbid states that occur more

frequently in the diabetic population. That stage was
begun in the year 2000, as changes were initiated in the
Department of Preventive Medicine to help coordinate
simultaneous care in multiple disease states.

In that year, efforts were made to coordinate the
Care Management areas of Diabetes Mellitus (DM), Coronary

Artery Disease (CAD), Congestive Heart Failure (CHF), and
Asthma (as well as Elder Care, End Stage Renal Disease

[ESRD], and Perinatal Care). These efforts resulted in

greater understanding and greater cooperation among these
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Care Management areas. Ultimately .the nurses involved in
care managing. Diabetes Mellitus,;.Coronary Artery Disease,
Congestive Heart Failure, and Asthma have all joined the

Department of : Preve'ntive . Medicine in tracking,
preventing, and managing the progression of chronic,
diseases. An important Component of.the care management

model of care is Continuous Quality Improvement (CQI) and
feedback of results. That has formed the basis of the

.

present goals.and objectives of the. Preventive Medicine
Department in Fontana.
Finally, by 2001, the expertise in care management .

was beginning to produce results in developing a new
model of diabetes care. Diabetes Nurse Specialists.were

cross-training in cholesterol management and had begun to
interact with other care managers in other departments. A

Registered Nurse Practitioner (RNP) was hired to address
more complex cardiac cases. All the nurses and Clinical
Health Educators were trained in computerized outreach

toward defined disease populations. The staff of

Preventive Medicine was always included in the
development of this new model of care. Eventually, the
lingering problem of reaching the at-risk individual was
addressed by this present study. "How does one reach the

■

■
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person with difficult to control diabetes when
transportation or time constraint hinders care?

Implementation of Preventive Services
Since Preventive Medicine had evolved from a purely

Public Health perspective and educational perspective, it

is important define the arena in which Preventive
Medicine operates. The definition of Preventive Medicine
as it appears in Stedman's Medical Dictionary (1972) is
"a medical specialty primarily concerned with prevention
or disease and the promotion and preservation of health
in the individual", has given way to a more comprehensive

and outreaching definition used by the Accrediting
Council for Graduate Medical Education (Green Book) 2000.

"The primary foci of Preventive Medicine are the study of
disease processes as they occur in communities and

defined population groups, and the stimulation of
practices with respect to the community and the
individual that will advance health by promoting health

enhancing environments and behaviors, so preventing
disease and injury, making possible early diagnosis and
treatment, and fostering habilitation and rehabilitation
of persons with disabilities."
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The major changes in definition center around the

study of defined population groups, the involvement of
entire disease processes, and the outreach involved in

promoting health within these populations. This has
formed the basis for developing goals and objectives for

the Department of Preventive Medicine in Fontana. First
and foremost, we must strive to improve the health of all
our diabetic members. This population numbers

approximately 15,482 people using data derived from our
diabetes population registry. Second, we must provide

comprehensive diabetes education and training in addition
to all other activities. Third, we must continue to

supply over 2000 individual appointments per year and
over 3000 class and group appointments. Fourth, we will
continue to receive over 2200 new referrals per year that

add to our population. Fifth, we will start over 500

people on insulin this year and follow up on their
education and management. Sixth, Care Management

initiatives have now included the ability to outreach to

groups we have missed in the past. We will also have

greater effect on outcomes of,the various diabetic
complications that are impacted by Population Care

Management. Seventh, Clinical Information Systems (CIS)
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provide the means for following our defined diabetic
population from cradle to grave (only after a long

productive life). Eighth, We have developed a focus on
measurable outcomes; this is a crucial point upon which a

Continuous Quality Improvement (CQI) program will assist

care providers with the tools for improving care and
changing the processes by which care is provided. As
noted in the work of Peters and Davidson (1998),

information technology (IT) has become an indispensable

tool in the provision of Preventive Medicine to a growing
population. Besides registering and tracking a
population, a computerized database allows complex
searches for common attributes among at-risk individuals

and provides an ideal outreach tool. The ability to track
a subpopulation,permits individualization to a single
department, a single medical office building, or a single

practicing physician. Resources can be directed to assist
individuals or outlying medical offices that have a high
number of significantly at-risk patients. This concept

has permitted the Department of Preventive Medicine to
direct more care to people who have not benefited from
traditional, centralized care. We are finally able to

develop outreach programs that extend our sphere of
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influence to the furthest reaches of our Medical Service

Area. That satisfies the requirement that Preventive
Medicine go out into the: wider community to promote
health and prevent disease.

Diabetes Outcomes

Diabetes Mellitus (DM) is a serious, chronic disease

that affects over 15.7 million people (5.9% of the

population) in the United States. According to the
American Diabetes Association's Diabetes: 1996 Vital

Statistics (1996), approximately 800,000 people are

diagnosed every year and that number is considered to be
an epidemic in The United States. Many people are not
aware that they have diabetes until they develop a
life-threatening complication. Diabetes is the seventh

leading cause of death in The United States of America.
Diabetes contributed to 198,140 deaths in 1996 according

to death certificate data. For the purpose of determining
diabetes outcomes, we must look at the incidence of

complications. Cholesterol abnormalities associated with
diabetes contribute to a.two to four times greater risk
or a stroke or heart attack in the person with diabetes.
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Heart disease is present in seventy five percent (75%) of
all diabetes-related deaths in the United States.
The American Diabetes Association's web site

(Accessed October 16, 2001) cites diabetes as the leading

cause of End Stage Renal Disease (ESRD) in this country.
Over 51% of all people on dialysis are receiving
treatments due to diabetic complications. Diabetes is
also the number one cause of new cases of blindness in

The United States among people ages 20-74. Between 12,000

and 24,000 people lose their sight because of diabetes

every year. Additionally, a,person with diabetes has a
15-40 times greater risk of amputation compared to a

person without diabetes. There are more than 56,000
amputations performed each year among people with
diabetes.

Much attention is paid to the economic impact of
Diabetes Mellitus. One in seven health care dollars are

expended on diabetes-related disease in The United
States. According to the American Diabetes Association's

publication on diabetes costs (1996), the direct and
indirect costs of diabetes now exceed $100 billion per

year. It is one of the most, costly health problems of our
times.
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Improving diabetes outcomes has been the aim of many
scientific studies. Despite the fact that improved

glucose control would appear the most obvious way of
improving outcomes, it was not until the DCCT (Diabetes
Control and Complications Trial) of 1993 that the
dramatic degree of improvement in the outcome of Type 1
Diabetes could be fully demonstrated. This was followed

by the UKPDS (United Kingdom Prospective Diabetes Study)
in 1998, which demonstrated that people with Type 2
Diabetes had significant improvement in outcomes
associated with improved glucose control. The outcomes

studied included Retinopathy (Ocular Disease),

Nephropathy (Renal Disease) ,. Neuropathy (Neuronal
Disease), and Cardiovascular (Heart) disease.

The measurement of glucose control in every study
has been the determination of Hemoglobin Ale (HbAlc) as

well as Self-Monitoring of Blood Glucose (SMBG) values

recorded on home blood glucose monitors. Hemoglobin Ale

is an objective laboratory study that integrates three
months of glucose concentration in the blood. Whereas,

SMBG gives isolated values spread over a short period of
time. This is useful for day-to-day management of blood

glucose, but lacks the ability to give an average

measurement of glucose concentration. The HbAlc is used
as the sole measurement of glucose control in this study.
Diabetes outcome studies, such as Greenfield et al.

(1995), use surrogate markers to evaluate intermediate

steps toward improving the health of a defined
population. As previously mentioned, the Hemoglobin Ale
test represents the integration of average blood sugar
values over a 90-120 day period. This is most commonly
used as a marker for clinical improvement over a two to
three-month period of time. That data if further
extrapolated to clinical outcomes.

The frequency of performing a Retinal Screening
Examination in a diabetic population is a surrogate for
care performed at appropriate intervals in that

population. As we have learned from McCullough et al.,
(1998), the ability to coordinate care for a large group
is modeled by performing a yearly retinal exam on this

defined population. The yearly retinal examination also
translates to an improved quality of life, since each
case of early Diabetic Retinopathy detected by screening
lessens the chances of permanent blindness in the

population group being evaluated.
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Urinary MiGroalbumin (MA) testing is a surrogate
marker for prevention of End Stage Renal Disease (ESRD).
As we have learned from McCullough et al., (1998), yearly

urinary Microalbumin screening improves the chances of
early detection and treatment of Diabetic Nephropathy,
which eventually leads to Chronic Renal Failure (ORE),

The earliest stages of this process are reversible, and
initiation of proper treatment may delay progression in
later stages. This is also a marker for improved quality
of life, since the outcome of poor control is death or
dialysis treatment.

The performance of LDL-Cholesterol as we have
learned from McCullough.et al., (1998), is directly
related to initiation of treatment with behavioral

modification as well as with pharmacological treatment.

The higher the LDL value, the greater the risk for a
Myocardial Infarction (MI) or a Cerebral Vascular
Accident (CVA). Lowering the LDL value has the benefit of

improving overall health and improving quality of life.
This test also has the benefit.of motivating individual

patients toward making the lifestyle changes necessary
for achieving better health. In order to further improve
the individual health outcomes, a pharmaceutical agent is
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often added as an adjunct to the behavioral changes. The

appropriate attention to total health outcomes is a
critical factor in reducing the risk factors for serious
diabetic complications.

Clinical Practice Guidelines

Clinical Practice Guidelines (CPG) are

evidence-based recommendatiohs. that are agreed upon by a

panel of experts that direct a specific course of action
within medical decision making. These guidelines are

clinically useful in the determination of appropriateness

of ongoing medical care. Every medical field has Clinical
Practice Recommendations (CPR) specific to that field.

Wagner, Austin, and Von Korff (1996) is a proponent of
Clinical Practice Guidelines as a means for dealing with
chronic illness.

Diabetes guidelines, such as the Clinical Practice
Recommendations (2001) of the 7\merican Diabetes

Association, govern the type and frequency of specific

testing procedures. The goal is to always improve

clinical outcomes with respe.ct to resource utilization.
The frequency of performing a diabetic Retinal Screening
Examination is set at one-year intervals. This period of
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time was chosen due to the slow progression of
sub-clinical .Diabetic Retinal disease. Intervals over one

year generally demonstrate a decrease in the quality of.
care delivered.

.

Hemoglobin Ale testing is done at intervals that

would influence or change the care of an.individual
patient. This interval could be. from one to eight times
per

year.

However, the minimum interval is set appropriately
at once per year. This gives much leeway toward
approaching the upper, end of the interval, but dropping
below, once a year would hinder proper care. For the

purpose of this study, we have evaluated Kaiser Health

Plan members who have had HbAlc values in the past 12
months and we have used this.value to. stratify,.our.

population for the purposes of determining the course of
their care.

HbAlc values indicate' the degree, of glucose control

during the prior three months. American Diabetes
Association .publications such.as Medical Management of

Type 2 Diabetes .(19.98) quote, that ."Excellent control" is
generally, cited as. less than 7%, "Good control" up to 8%,.
"Fair control" up to 9%, and."Poor control" greater than

•
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or, equal to 9%. The.ADA Clinical Practice Recommendation
is to improve HbAic as much as possible, and to address
HbAic values of 9% or greater as a priority group

requiring greater attention and treatment.
Urinary Microaibumin (MA) is measured at yearly
intervals in the early stages of Diabetic Retinal
disease. The clinical goal is to maintain the MA value at

less than 30 mcg/mg creatinine. This value is associated
with less risk of progressive Diabetic Nephropathy and is
associated with reversible changes within the renal

parenchyma. Treatment may consist of improved glucose
control and/or pharmaceutical intervention.

The frequency for measurement of, Low-Density

Lipoprotein (LDL) Cholesterol is cited in the ADA
Clinical Practice Recommendations (2001) as at least once

per year. Elevation of LDL-Cholesterol is directly
related to the risk of Cerebral Vascular Accident (CVA)

or Myocardial Infarction (MI). Clinical Practice
Guidelines suggest that LDL-Cholesterol be maintained at

less than 130 mg/dl. Many specialists now prefer to keep
this value at less than 100 mg/dl. The Fontana Diabetes
Clinic uses this value for the initiation of treatment of

elevated LDL-Cholesterol. The percentage of the
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population in good control of Cholesterol is an important
marker of potential Atherosclerotic Heart Disease within

a population. Cholesterol treatment helps to
significantly lower coronary heart disease risk. The

percentage of the population at-risk for elevated
LDL-Cholesterol that receives treatment is an important
measure of active medical treatment plans aimed at

lowering the incidence of coronary artery disease within
a defined population.
Dissemination and promotion of Clinical Practice

Guidelines are essential in improving the health of all
care-managed populations. The closer the population
approaches the ideal standard, the better the health
status of the individuals comprising the population. That

is why many Continuous Quality Improvement programs

concentrate on bringing their populations closer to the
ideal standard promulgated by Clinical Practice
Guidelines.

Diabetes Quality of
Care Measures

,At first. Quality of Care (QC) in any medical

context may be an elusive concept to quantify. How do you
measure the caring of the physician or the skills of the
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nurse? Therefore, measurable outcomes in improvement of

clinical health status become the measurable quantities.
The areas of diabetes care most often cited as Quality of

Care Measures (QCM) by national standards organizations
(HEDIS 2000) are: Frequency of Retinal Screening
Examinations, frequency of HbAlc measurements, frequency,

of urinary Microalbumin monitoring, and frequency of
LDL-Cholesterol measurements. Secondarily, the

improvement in HbAlc is used to assess the outcome of any
diabetes intervention. In addition, treatment of abnormal

values of urinary Microalbumin and elevated values of
LDL-Cholesterol are measures of the efficacy of the

process of delivering care. Used together, these Quality
of Care Measures are powerful tools in assessing the

impact of any clinical intervention.
A diabetic Retinal Screening Examination is defined
as a dilated eye exam performed by a licensed

professional within their Scope of Practice that includes
evaluation or interpretation of Diabetic Retinal changes..

A non-dilated photographic study may be used if it is
evaluated or assessed for Diabetic Retinal changes by a

Licensed professional tnained in the. evaluation or.
interpretation of Diabetic Retinal Photographs. The
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standard of care by national standards organizations

(HEDIS 2000) for performing this test is a yearly
examination in all diabetics, except those people having

Type 2 Diabetes for less than 5 years. The interpretation
of this Quality, of Care Measure is that any qualifying
exam performed within a 12-month period is indicative of
a higher quality of care, and any examination not

performed within a 12-month period is indicative of a
lower quality of care.

Urinary Microalbumin monitoring defined as a urinary
assay for the protein albumin, which is capable of

quantitative measurement within the range of 30-300
mcg/mg creatinine. The measurement may be performed on a
first morning sample, a random sample, or a timed urinary

sample. The value must then be recorded in a medical
record in order to be interpreted. The standard of care

by national standards organizations (HEDIS 2000) for
performing this test is a yearly examination. The
interpretation of this Quality of Care Measure is that

any qualifying exam performed within a 12-month period is
indicative of a higher quality of care. And any
examination not performed within a 12-month period is
indicative.of a lower quality of care.
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Low Density Lipoprotein (LDL) measurement is defined
as a quantitative assay of serum LDL that has been

performed at a facility that meets CLIA (Clinical
Laboratory Improvement Amendments) standards. This may be

performed as part of a fasting lipid test or a
non-fasting test. The value for LDL may be calculated or
direct. The standard of care by national standards

organizations (HEDIS 2000) for performing this test is a

yearly examination. The interpretation of this Quality of
Care Measure is that any qualifying exam performed within

a 12-month period is indicative of a higher quality of
care. Any examination not performed within a 12-month

period is indicative of a lower quality of care.
The frequency of HbAlc measurements is dependent

upon the type and severity of diabetes. Type 1 Diabetics
are insulin-dependent and ketosis prone. The frequency of

performing HbAlc in this population is cited by the
American Diabetes Association Clinical Practice

Recommendations (2001) as at least twice a year. More

frequent tests are done when trying to optimize glucose
control. Type 2 Diabetics are non-insulin dependent and
non-ketosis prone. Their standard for performing the
HbAlc measurement by national standards organizations
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(HEDIS 2000),is cited as at least once per year. The

interpretation of this Quality of Care Measure used by

this study is that any qualifying exam performed within a
12-month period is indicative of a higher quality of
care. Any examination not performed within a 12-month

period is indicative of a lower quality of care.
The improvement in HbAlc can be demonstrated in two

ways. First, separating the HbAlc values into quartiles
allows one to demonstrate changes over time among the

quartiles for, "Excellent", "Good", "Fair", and "Poor"
glucose control. The values for these quartiles are:
HbAlc less than 7.0% is "Excellent control", HbAlc

greater than or equal to 7.0% and less than 8.0% is "Good
control", HbAlc greater than or equal to 8.0% and less
than 9.0% is "Fair control", HbAlc greater than or equal

to 9.0% is "Poor control". Percentage changes between

quartiles are evidence for clinical changes in the,study
population.
The second method of demonstrating improvement in

HbAlc is by direct measurement of HbAlc before the
intercession and after the intercession. This may have

two phases: an early HbAlc change as well as a later
HbAlc change. The improvement or worsening of values can

38

be evaluated for degree of change by a standard
statistical analysis.

Finally, the outcomes of a treatment intervention

may be measured by the number of abnormal laboratory
values that receive appropriate treatment. This would
include treatment of elevated urinary Microalbumin values

with an Angiotensin Converting Enzyme (ACE) inhibitor or
other equivalent treatment, or treatment of elevated
LDL-Cholesterol with a "statin" lipid lowering drug or

other equivalent treatment. The quality of care standard
is to treat the abnormal value. The Interpretation of

this Quality of Care Measure is that any prescription for

an appropriate drug within a 12-month period is
indicative of a higher quality of care, and the absence

of any prescription for an appropriate drug within a
12-month period is indicative of a lower quality of care.

Diabetes Models of Care

The models of care that are used for providing
medical attention to a diabetic individual or to a

defined diabetic population vary widely. According to the

study by Hayes and Harries (1984), they may include doing
nothing (a minimalist approach) or providing one-to-one
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physician contact on a daily basis (the private hired

physician approach). The approach used to monitor or
manage a large population must include appropriate

resource allocation as well as information management.
Physician extenders become mandatory with larger
populations.

The role of the Diabetes Nurse Educator has grown
over the past ten years as described by Wagner (1998) in
the Annals of Internal Medicine. Initially, a Registered
Nurse was member of the health care team whose role was

to follow specific physician orders to administer

medications, provide palliative care, and basic personal
hygiene, as well as educate and console. Very little
deviation was allowed from this traditional model of care

in nursing.

.

However, over time, the Outpatient Clinical Nurse
Educator was given protocols that gave this individual
the ability to act on the doctor's behalf as an
interpreter of clinical protocols for one individual

patient. At this stage, the Registered Nurse could assist

a diabetic patient in increasing his/her insulin dosage
by a small amount only by referring to a specific written
instruction written by a physician for this patient. From
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this early beginning, the more complex protocols of today
developed.
As other medications became available for the

treatment of diabetes, the existing nursing protocols
became more complex Policies and Procedures that

permitted changes in classes of drugs as well as
permitted adding new drugs to an existing regimen all the
while being closely mentored by a physician who remained

responsible for prescribing the individual medications.
The more complex medical regimens lead, to more

sophisticated monitoring of drug reactions. The nurses
were given additional Policies and Procedures that

permitted them to stop medications, order appropriate
blood tests, then restart the same medication if the

testing was negative.
This expanded role, of the clinical diabetes
practitioner has lead to the development of the Certified
Diabetes Educator (ODE) certification. Skill in assessing

difficult situations as well as recognizing clinical
scenario became a foundation of the job of Clinical
Diabetes Nurse Educator. These nurses assess compliance,
determine the degree of diabetes control, change

treatment parameters, and follow up on complications and
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problems that fall within their clinical nursing Scope of
Practice.

The present model of care for our diabetic members
at the Kaiser Permanente Medical Center in Fontana had

evolved to the point that Registered Nurses and

Registered Dietitians teach ail of the diabetes classes
in our clinic. The Nurse Care Manager triages phone calls

and manages medication changes by phone with approval of

the Physician mentor. The Nurse Care Manager reviews
abnormal laboratory values and discusses medication

changes with the Diabetes Specialist. The Clinical
Diabetes Nurses interact individually with their patients

and teach the most effective ways of maintaining

excellent glucose control. They also start new diabetes
medications based upon strict diabetes management

protocols.
Primary Care Physicians have indicated that they

would prefer to have the Fontana Diabetes Clinic
(together with Dr. Hess, the Endocrinologist) manage
their diabetic patients. The clinic has been able to

order appropriate laboratory tests on active patients and
monitor the results of those tests. Abnormal values are

communicated back to the primary physician for treatment
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or further'study. Diabetes mediGatiohs are optimized, and
glucose■control improved under strict protocols.
Folldw-up appointments, are made at the Fontana Medical
Center in drder to maximize the use of the nurses'

time.

Eventually,, it .became; evident that the Kaiser Health

Plan.members that did not improve over time were the

members who did not. show up.for appointments and did not
respond to phone calls and letters. Many of these.members
were assigned to physicians in the outlying medical
offices as far away as Pomona and Victorville,

.

California. There had to be a way;to .place a highly
trained Diabetes .Nurse Educator in the outlying medical

offices such that.the quality of care issue brought to

light by having poorly controlled diabetic members could
be addressed in art effective manner. This .study describes

one .such model of care and atteinpts to define the
characteristics that make; this raodel. o.f care so
effective.

\'y .

Care Management

;

Care Management has been described by the SCPMG

;

Diabetes .Qutcome .Report .(2000.) as ."Improving the ■health)

of a population ..:one member; at. a time . 'c It applies the

:43

knowledge and science of.Public.Health to a chronic
disease arena. The critical cteps asv stated in the

article by Gurnee and Da Silva (1997) for applying Care .
Management to'a large population include 1) Identifying
the at-risk population, 2) Stratifying: the. population by

acuity, 3) .Tracking and monitoring interventions Upon the

population, .4),Developing: and implementing Clinical
Practice Guidelines, 5): Creating new, proactive
interventions (both outreach and inreach)

,

,

.6)

Coordinating care among various individuals,. 7). Measuring
outcomes,, and 8) Continuously improving the quality of
care

Defining an at-risk population is.bne of the first
steps in Care Management. .For diabetes, this is

accomplished by.the Southern California Permanent
Diabetes Registry Database. Fontana patients are a Subset
of that database, and all efforts are, measured thrpugh

that database. National quality,standard's for diabetes
care, such, as, HEDIS (2;Q00) are tracked through, this

database as well as through others., ,

, ,

Risk Stratification is a method by which the sickest

patients or the most'dt-risk .:patients, are identified and

categorized .by .their likelihodd of' developing significant
\. . ■ .
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.,

±llne:sS;,o

requiring, sigriifieant. interventi

This is

most . often,;.performed by examining ,,,the medical; record and
developing an algorithra,for ranking'individual^clinical ,

charact.eristics, such as, labbratdry^ r

,:.frequency of

, hospitalizat'lon,: and concurrent Illnesses. A .value is 1

then applied to this;rahkihg, thus allbwing cdmparisdn
among the members;, of the at-risk populatidns^^

..

.

, .

Tracking ihtervehtions that:;axe Subsequently .

;

performed upon the..population then becomes the focus of.
the Gare Manager.:; This requires':access to quantifiable
clinical data'that impaGts .the qverall health of the
study population. The .goal is- to improve: the overall :

health and move: as. many: peqple as possible from high risk
•to lower risk categories. . .

Clinical practice guidelines (CP.G)' are the: tools, for.
moving a large ciiaical pppulati.On . f.rpro higher v to lower,
risk. The : Physiciaps . and Care Managers.'bob^ try to

deliver the highest quality :ca.fe to ..those: people they
serve.. Having a stahdard by w

'

measure;.that care is .

critical:-to day-to-day tfe.atment, as well as to improving
future: treatment.:

Outreach .is an . important . component of . care . i ; .

management. This requires .identific:.ationq.f. people at

need for extra care. Outreach may take the form of a
letter or phone call. Newsletters and flyers are used to
address large numbers of at-risk individuals. Whatever
the means of communication, the goal is to provide better

diabetes care and, therefore, improve clinical outcomes.
Computers, as proposed by Peters and Davidson (1998),
have improved outreach programs significantly. Targeting
a population identified in the outreach process allows
intervention with the people at highest risk. The method

or encounter may be done one-to-one, small group, large
group, or classroom. Contact by phone. E-mail, or fax may
be sufficient in some cases.

Inreach involves the same technique applied to
at-risk individuals already, involved in an intervention

program. Some of their needs may be already met by their
medical care system; but there are always gaps in care
that must be identified, addressed, and treated.

Following the initial Care Manager contact, there

must be a way to identify the patient receiving care

management in order to affect long-term survival, such as
in the study by Verlato, Muggeo, Bonora, Corbellini,
Bressan, and de Marco, (1996). This assists the follow up
and patient tracking process. This also makes information

available to other care managers in order to avoid

duplication of effort. This ability to track a patient
makes possible the evaluation of the care managing

process and coordinate care among various providers.
Care Managers use tools to remind patients to

perform required laboratory testing. These tools improve
the delivery of care and facilitate compliance with
national healthcare standards such as HEDIS (2000). The

Clinical Information Systems (CIS) makes it possible to

access many forms of data simultaneously, including

pharmacy data, laboratory data, demographic data, and
hospitalization data. This information set ultimately
becomes part of the reporting set to employer groups and
the National Committee for Quality Assurance.

Finally, the techniques of Continuous Quality

Improvement (CQI) have crucial bearing upon the field of
medical care. The work of Dalzell (1998) shows that

feedback of data to care providers becomes essential.

Giving providers a yardstick against which they may
measure their own efforts provides a means for striving

to improve the standards of care. Those who exceed the
standard should be recognized and rewarded for their
efforts. Those who under-perform the standard have the

47

opportunity of learning from their'.pee^^

Gver, time;, .as 

observed by MacKinnon, (1990), t:b^^

of the

pOpulatioh will improve tp bh■optimum point possible with

existing resources. Study :df ,thd popuiation also promises
to demonsbfate how to best utilize those, resources. The

best measure of. quality imprbvement is a healthy patient.

ClinicaT Tnformatibn Systems
.Clinical:Information Systems

^

(CIS) . serve several,

purposes. First, they must access legacy, systems that . .

store individual 'demographic data, clinical..medical data,
laboratory data,.ihospitalization data, and intervention

data. Second, they, must link the databases served.by the
legacy systems in order to permit "data mining" for
clinical purposes. Third, these linked systems permit the
formation of data registries that hold the key to

identifying at-ri.sk .populations. Fourth, the at-risk

population may be. stratified through the use of clinical
data, and bhis data used as an' outreach, as well as .

inreach, information tool. Fifth, pa.tient..tracking and

monitoring involves a separate tool, that has been brought
down to the provider level. Sixth, a measurement and
communication tool has to be .developed, in order to

disseminate Clinical Quality Information to the

appropriate medical provider.

Legacy systems, such as those described by Shea,
Du Mouchel, and Bahamonde (1996), often share the

attributes of incompatibility and lack of data
standardization. Assuring that the data obtained from

these systems matches the needs of the clinical care
provider is a difficult undertaking. This is due to the
fact that one is extracting data not initially intended

for this ultimate purpose. For example, hospitalization
data has traditionally been collected for use by the

hospital. Obtaining this data often requires a thorough
understand of five to ten separate data formats and
programming languages.

Linking incompatible databases often requires
setting up yet another database that stores merged data.

This requires frequent updating of information and may
introduce a source of error. This requires that data be

analyzed before releasing it for use by the care
provider.

Data registries, such as those of Baker et al.
(2001) at the MayoClinic, are the result of analyzing

clinical date on an identified population. The population
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can be categorized by the presence or absence of a
clinical condition, such as diabetes. This is done

through the use of identifiable characteristics, such as
blood glucose values. These clinical data registries form
the basis of all monitoring, tracking, and interventions.

This data is frequently used by National Quality of Care
organizations, purchaser groups, as well as by the
providers in the medical organization.
Risk stratification identifies the characteristics

of group members at-risk for significant mobility or

mortality. This helps to provide a continuum over which
the entire population may be placed. These data form the
basis of outreach and inreach initiatives. This also

allows for the placement of scarce resources where they
will have the most impact on the population.

Care providers will see only a portion of the
overall data as it applies to their individual patient

population. The ability to track the improvements in
health of any individual holds the potential to raise the
standard of health of the entire population. Each

provider can monitor normal and abnormal laboratory
values on his/her patients and subsequently provide an
intervention that will move their patient closer to

50

optimum health status. Using a patient tracking .system
acts as a behavior modifier for the provider and as a
motivator to continuously improve cafe.

Finally, the ontcomes of this clinical intervention
must be .collected, analyzed, and reported. The provider
must be able to see the, fesult of his/her work. The Care

Managers, such as those in; the Weinberger et al., (1995.)

study must be able tO; assess .the efficiency, of.their
interventions with the populations. The clinical quality

managers, must be able to spot, tends, that, would detract

from care and that would improve care in used more

widely. .Patients should witness their own health
improvements, and the purchasers of health ; care .should ,

see that their health care premiums are well, spent. The
national quality standards organizations, also: hope to

;identify best practices among 'health,, care organizations
for the purpose of disseminating the most useful health
care practice models,. ,

, ,

Tracking Care Impfbyement

Quantifiable outcomes arq necessary for evaluating

any medical interventiont These outcomes may be measured

by frequency of hospitalization Or mortality. However,
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these are considered to be very long-term outcomes.
Intermediate outcomes need to be developed in order to

assess progress towards long-term outcomes. That is why
surrogate outcomes are used to model the health status of
an at-risk population group.

Hemoglobin Ale is a measure of glucose control over

a three months period of time. However, it is used to
model the health of a diabetic population since it is
directly correlated to the incidence of chronic diabetic

complications. In the DCCT trial of 1993, the' incidence
of new Diabetic Retinopathy was reduced by 76%. The
incidence of new Diabetic Nephropathy, was reached by 50%,
and new Diabetic Neuropathy was reduced by 60% in a

population composed of Type 1 Diabetics. The UKPDS study
of 1998 showed that improved glucose control reduced the

risk of requiring Retinal Photocoagulation by 25%, and
the risk of Myocardial Infarction (MI) by 16% in a Type 2

Diabetic population.,This has significant clinical impact
upon the entire diabetic population and is often cited as
a reason to promote Diabetes Care Management.

Performing the Diabetic Retinal Screening
Examination at regular intervals permits the detection of

treatable stages of Diabetic Retinopathy. Early treatment
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will generally delay the progression to blindness that
results from this,disease. Therefore, it is used to

assess the degree of care in a diabetic population. In

addition to lessening the risk of permanent blindness,
the documented Retinal Screening Exam permits outside
reviewers, such as NCQA, an assessment tool in

documenting the care processes of a health care
organization.

Urinary Microalbumin is a critical tool for
assessing the presence of Diabetic Nephropathy in a
diabetic population. It also tracks the progression of
this disease over time. Once proper treatment is
initiated for Diabetic Nephropathy, the urinary
Microalbumin is used to assess the efficacy Of the

treatment intervention. Lack of monitoring of this marker
for chronic complications demonstrates poor surveillance .

techniques for an at-risk population. Producing a list of
untested individuals permits a Primary Care Physician .

(POP) or Care Manager (CM) the means for scheduling and
performing the proper testing. This list also forms the

basis, of one arm of the outreach program by identifying
under-served individuals in-the population.
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Monitoring.LDL-Cholesterol is a much more global
marker for overall health outcomes since over 75% of

people with diabetes ultimately expire from

atherosclerotic disease complications. Improvement in

■

LDL-Cholesterol values tracks the improvement in
cardiovascular risk. The use of;pharmaceutical

interventions in this population promises to

significantly impact the mbrtality figures for Coronary
Artery Disease, in ..this population, Following up on ;
treatment is one method by which the care, manager impacts
the overall health of the population that is being
followed. The importance, of tracking care improvement is

essential to the, mission of a preventive care

"

organization.

Compliance/Adherence
Adherence to any medical regimen,is important in
determining the outcome of treatment. In Gurnee and
Da. Silva-s 19.97 article on constructing disease

management prbgrams:,, the. regimen that is adhered to. the
best will, have the .greatest effect on the health of the
population under study. Several factors that determine
adherence are:. simplicity, clarity, relevance,

5.4

accessibility, and reinforcement

Other factors include:

age, maturity, and educational level. However, these

factors are less modifiable than those previously
mentioned.

Education is necessary to elicit compliance when the
tasks involved are either complex or do not show obvious
connection to readily perceptible consequences. Diabetes
self-care is not particularly complex, as Peters and
Davidson discuss in their 1995 article. However, the

general population of the United States of America
continues to move further away from good health

principles in its diet and activity regimen. We are
becoming grossly overweight and in poor physical
condition. Efforts must be undertaken to prevent this

decline in our community health. Studies published by the
American Diabetes Association, referred to in Diabetes

Mellitus (1999) have shown the connection between poor

eating habits, increasing weight, decreasing activity,
and the onset of chronic conditions such as Diabetes

Mellitus. Many people with this diagnosis are in denial
of the seriousness of their disease. This is evidenced by

the increased profitability of herbal remedies that

purport to improve, and even cure hypertension, diabetes,
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and heart disease. However, the failure of alternative

treatment eventually leads to.complications and even

death. This Is an Inescapable truth that needs repeating.
The explanation of simple concepts Is Important but
time-consuming. Many Physicians lack the time needed to
adequately address the Issues and educational needs of
their diabetic patients. That Is. why diabetes educators,
such as In the study by Weinberger et al. (1995), are a
necessary part of the diabetes treatment team. Patients
tend to comply with what they understand best. The

simplest explanation Is. often considered the best.
Bringing the message down, to the proper grade level often

makes It more accessible to the listener. Language Is
another barrier to learning that must be overcome by a
skilled Instructor. That Is a compelling reason to have a

diverse staff working In the Department of Preventive
Medicine.

Making, this topic relevant Is an Important tool In

achieving adherence to a self-care regimen. Everyone has

a unique background and comes from a unique environment.
The ability to address a group of people and
Individualize the experience for each person Is a
considerable task. Diabetes educators are trained to
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facilitate learning by finding common experiences in a

'

group of individuals and extracting relevant information

that assists the learning process for the entire group.
The location at which the care is provided should be
convenient to the individuals being,treated. The further

away the facilities of care the: more, li.kely that.members
of the target population will be missed by the planned
intervention... The clinic where the member has a Primary

Care Physician and where the. member obtains the majority
of his/her care is the ideal Ipcation for a highly
successful intervention. ■

Repetition.aids learning and provides positive

reinforcement. Patients appreciate the concern
demonstrated by a return phone call. This simple
intervention permits the care manager to. keep closer tabs,
on the individuals that are followed and address any

concerns that could'have otherwise hindered appropriate .
■care .. ■

■'/

■;....: ■

, 

Authority Figures in
Medical Studies

. Studies completed in the 196.0' s by Stanley Milgram
(Obedience to A.uthority, 1974) demonstrate that people

are prone to obey those in authority even under extreme

.
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circumstances. This is evident when one experiences the
"white coat mystique" upon entering the doctor's offices.
Physicians have long been considered authority figures by
the public and by those that work alongside them. The
public is much more likely, to obey a medical

recommendation if it is reinforced by a "Doctor" than if
it were recommended by another ancillary medical

personnel. This effect is perceptible even when actors
portray physicians on television commercials.
The use of a Physician in emphasizing the need for a
lifestyle change can make the difference between

adherence and non-adherence. This effect is amplified if
the Physician , is the same Primary Care Provider who has
already established a relationship with this patient.
The Physician as authority figure also provides a
source for enforcing logical consequences with the

patient. Many people will cooperate with a treatment plan
so that they do not disappoint their family doctor. The
physical presence of this Physician in the examination

room emphasizes the importance of the issues addressed by
the treating Clinical Nurse Educator. People perceive a

greater value in an appointment in which their own Doctor
has made an appearance.
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The presence of a Physician in a group setting makes
the patient more confident that the information being
given is medically correct. There is now a central figure
that can take responsibility for the care being provided
to the members of the group. The Physician is seen as the

coordinator and ultimate provider of any intervention
made during this appointment, even if the intervention
was made at the recommendation of the Clinical Nurse

Educator.

Time and Place Utility
As was previously stated, the location for
delivering care may be determining factor between

adherence and non-adherence. Any study of care delivery
and models of care must look at the most appropriate
location for that care, as was reported by Hayes in 1984.
If traditional care was held in a centralized location,
then non-traditional care must look elsewhere if access

to care is a critical factor. The location may be within

a few miles of the home itself. House calls may be done
in person, over the phone, or over the World Wide Web.
There does not seem to be any means of communication that
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is considered to be too convenient. Both time and place

must be considered in planning an intervention.
In a population that may be hampered by

transportation-related issues, both time and place
utility come up as critical factors in providing

appropriate care. If the initial appointment was
successful in obtaining the cooperation of the patient in
his/her own care, then the follow-up contact has to be

equally as appropriate in time and place. This is the
obvious scenario for phone contact. The patient has

already encountered the Clinical Nurse Educator in the
clinic setting with, their Primary Care Doctor as the
initiator. A relationship of trust has been developed
between the patient and the nurse. Now, reinforcement of
the educational objectives may be accomplished at one'S;

leisure by phone, and the nurse is free to suggest other

changes to follow the successful changes made previously.
This is the ultimate goal of the Care Manager, that the
patient be the main focus of the care management program

and that the process of Care Management be the transfer

of information by means of telecommunications. This
allows the Care Manager sufficient time to assist many
individuals in a single workday.

,
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Group Dynamics
The manner in which care is delivered is as

important as the location of its delivery. The Group
Medication Model is successful not only due to its

ability to reach more people, but. due to its ability to
facilitate interpersonal interaction. People are social
beings. This concept was explored by Ho et al., (1997)
when examining the model of care delivery at the
centralized diabetes clinic. Their behavior is changed

when they go out in public. Opinions are often formed by
group norms. The use of a group for the purposes of
teaching lifestyle changes goes back to prior to recorded
history. The dynamics of group interaction plays a
pivotal role in shaping human behavior.
People frequently assume well-defined roles when
interacting as a group. One or more individuals are seen

as leading the group. Others are seen as active

participants, others as passive participants. If the
leader has sufficient skills then most other participants

should see themselves as active group members. Well-run

groups participate fully in the educational process by
asking questions and assisting others in the group to
understand the responses. Ideally a diverse group will
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have answers to Frequently Asked Questions among the
participants. 'People are naturally curious as to the.
insights of other group members. This allows those

members-who ask the questions to see. that others likely
share their opinions ...When . some individuals in a group
show enthusiasm for the message being taught, the passive
participants, tend to show consensus; with the group.norm. . .
People that would otherwise, be slow in accepting a
message may quickly accept the message., in order to be

perceived as part of a.group. Therefore,. group messages
tend to be effective if the majority of the group members
embrace, the message.

Group appointments also tend to discourage

,

disruptive behavior. .Disruptive group members can always
be invited to an individual appointment or be asked to
discuss their concerns after .the session has ended. The

group facilitator must be well versed in group teaching
skills. That is why sufficient time must be given to the

facilitator of the group for developing rapport with the ;
multiple group members.
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CHAPTER THREE

REPORTING OF FINDINGS

Restatement of the Problem

For many years. Primary Care Physicians have had
little time to spend instructing their own patients on
the correct manner for taking care of one's diabetes.
This shortened period of time meant, that some of the

complex needs of patients with diabetes were not being
met in brief problem-oriented office visits,. This led to
the creation of specialized diabetes clinics, such as

those described by Ho et , al., (1997) that brought
together the personnel and resources needed to, meet the
needs of those diabetic patients. This exact,model for a

centralized diabetes care clinic exists presently in the
Fontana Service Area,of the Kaiser Permanente Health Care

System.

However, this trend raised concerns among Primary
Care Practitioners in Britain, with the publication of

studies by Farmer (1990), Koperski (1992), and Pringle
Ward, and Chilvers (1993), where a Primary,Care Model
exists within a socialized medical structure. There was

sufficient impetus to create a series of chronic disease
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"mini clinics" that attempt-ed to iricorporatethe teachihg

.and specialized care of the centralized diabetes clinic
model into the realm and domain of"the: Primary .Ca.re :
Provider.

■

These "mini clinics" were, comprised of patients .all \

with a specific disease entity into a specially designed

visit with a team approach to.care. These clinics met at.
regular intervals and were shown to impiroye glycemic

control and reduce hospitalizations/ 
The present study incorporates yet another care

design that was not feasible 15 years ago. The Diabetes
Nurse Care Manager has been trained to evaluate and

assess the physical, social, and medical needs of
individual patients as well as at-risk diabetic

populations. Through the use of computerized case-finding
tools and electronic database.management techniques, the
Diabetes Nurse Care Manager identifies, arid then follows,

an at-risk population for trends in each individual's
care. This job entails scheduling offide;visits,
laboratory testing, ophthalmology visits, and monitoring
changes, in glucose control, in much the same way as the

study nurses acted in Wagner's study published April of.

this year. The nurse intervenes with letters, office
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•

visits, phone calls. The Diabetes Nurse follows a strict

protocol for changing medication dosages as well as for
adding or starting new diabetic medications. The
frequency of this intervention depends upon the severity
of the illness. The recording of clinical data, as well

as the analysis of that data is an important part of the
role of the Care Manager.. . This Quality of Care (QC) data
allows each Diabetes Nurse Care Manager to determine the

impact he/she had on the diabetes population being
followed. This study is the report of the first two (2)
Diabetes Primary Care Group Visit Model clinics held in
Colton, California and Victorville, California during the
year 2001.

Scope and Limitations
This study is being conducted entirely with members
of the Kaiser Health Plan that are managed by the
Southern California Permanente Medical Group (SCPMG).
Founded in 1945, Kaiser Permanente is the nation's

largest nonprofit health plan serving 8.2 million
members. There are over 3 million lives (3,052,644)

covered by the Kaiser-Permanente Health Care System in
Southern California as stated on the Kaiser-Permanente
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Intranet site (accessed September 27, 2001). In the
Fontana Medical Service Area there are approximately

371,000 active members. Of this number there are 15,482

individuals (4.2 percent) identified as having Diabetes
Mellitus. A nonrandomized longitudinal study was

conducted on a subset of this population being followed
in the Outlying Medical Offices of Colton and Victorville
in the Fontana Medical Service Area.

All participants are over 18 years of age and have
been Kaiser Health Plan members continuously for one year

preceding enrollment in this study. The patients being
studied had been chosen through the use of a computerized
relational database tool (POINT) that derives diabetes

data from Laboratory, Pharmacy, Hospital, Emergency

Department, Outpatient Department, and Demographic
Administrative databases to form an automated Diabetes

Registry. The principle criterion for inclusion in this
study was an HbAlc value of 8.9 and greater. Lists of the
at-risk diabetic population were created for each

participating physician in the Outlying Medical Offices
listed above. The nurses created lists only for those

physicians that wished to participate in a
shared-practice group visit model of care in which a
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Diabetes Nurse Care Manager helped that Physician manage

a higher-risk subset of his/her diabetic population.
There is insufficient evidence to note whether

cooperative physicians have .better or worse outcomes with:
their diabetic patients.. Therefore, this• population must
be considered to be a nonrandomized'sample.

.

/. The.patients that participated in this
shared-practiGe model had. agreed to come to' at least one
physician visit during which the Diabetes Nurse Care

Manager explained his/her role and limitations. He/she :
would also discuss general .Diabetes Care .Guidelines with

the participating members ... This would lead to some . degree
of bias towards ambulatdry- patients or pa;tients with

available., transpoxtatloh ....Patiphts

family or ,

community resources tend to.!'do^ better in their diabetes
care than, do those: patients, wholdo!/not have th
/■/ ;

. ■ ./

!'

The model,of care.described in this study is;in

.

resources./

; ■

addition to the presently .available centralized model of :
care utilized in the Pontana Medical Center Diabetes Care

Program. There are two /:2) Physicians/

seven . (7)

. Registered Nurse: Diabetes Educators, one (1) .Registered . .
Nurse Practitioner:, six . (6). Registered Dietician Health.
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Educators, four (4). Health Education Specialists/ two,. ,(2)

,Ph,D. .Public Health .(Dpctors of Health Scie.nce,,: ,0:ne^^^

pending dissertation)/land one Department. Adinihi.strator;
Ph/D. Public Health currently full. dr.;.p^^^^

time/;.All , ;

Kaiser Health plan.inembe.rs may access .'the Diabetes .Care
Clinic.; by self-referral, drv provider, ref.erral,. The

combination of classes., groups, and individual
appointments 'provided at .the Fontana Medical.VCenter would
.be the alternate care provided to : those who chose not to

participate .in,: the Istudy. All nonstudy participants are

.

derived . from .the/ diabetic population at large in the
Fontana Service Area

' .- . - ^

■/' ;■

.Finally, ,the .dhoice of selecting a range, of, .;

.

Hemoglobin Ale from 8.. 9 and above to represent a .

higher-risk group Was ..arbitrarily "based upon HEDIS 2000 ;
measures demonstrating poor vs. acceptable control for,
diabetic Health Plan members whose Hemoglobin . .Ale was

,
;

at-risk for exceeding 9.5%.

Sampling Plan

A Care Management tool (POINT) developed by. Pharmacy

Operations within Kaiser-Permanente was used to develop
the Intervention Population that: was followed by the
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.

Diabetes Nurse Gare Manager. This database system allows

queries to be undertaken;on a Southern California

Regioh-wide Diabetes Registiy. The Medical Center's. and

the individual Physician's. diabetes panel were easily
identified, using this;.tbo.l

A list of those.patients > 18

.years of age with a .Herhoglobin .Ale .>■ 8 . 9% Were presented
to their Primary .Care,PhysiGian .for approval. Each
Physician, was: given the pppprtunity. to ex.clude: patients

due to .unsuitability: to a group .format. If approved,

these patients were contacted by phone and/or letter
asking them, to participate in a two-hour doctor's visit
in which several Individuals will address,their diabetes

questions. It is at this point that some individuals were
excluded by refusal, .educational barrier, or language

barrier . . Approximately 45%. . .of" all invit.ed. patients never
attended a single.iclinic session. These..individuals were;
offered one-to-one counseling and management by a .

culturally appropriate Physician.or NurSe Educator.
■ The ,number of participants attending a group visit
appointment was often. 8-12 patients. When the group:of
selected members met with the Diabetes Nurse Care Manager

and .their Primary Physician, they received a
psychoeducational intervention followed by a review of
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their medical treatment and pertinent laboratory testing.

Those patients that needed any changes in medication got
those changes made on the spot. Pertinent laboratory
tests were ordered and performed the same day. The

Diabetes Nurse Care Manager was responsible for informing
his/her patients of the results of their tests and

maintaining phone and letter contact with his/her patient
population for at least one-year. However, for the
purpose of this study, each patient population was
studied for six months prior to their intervention as
well as six months after their intervention.

The data collected on each patient by each nurse at

every intervention was recorded in a clinical diabetes
database that served as an Electronic Health Record

(EHR). Further data for this study were available on

legacy mainframe computers that compile administrative
data, as well as demographic, laboratory, pharmacy, and

hospitalization data for the members of the Kaiser Health
Plan.

This has been an ongoing project of the Preventive

Medicine Department in Fontana even before the initiation
of the present study. This study was a nonrandomized,

longitudinal, statistical monitoring study that falls
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into the category of causal-comparative research design.
Therefore the intervention group was not subject to

investigator bias because this investigator had no input,
into patient selection.

Methods and Procedures

The population already discussed has been followed
for improvement in their Surrogate Care Parameters

(Frequency of performing HbAlc, MA, and LDL-Cholesterol)
as a measure of quality of care. During the course of the

study any changes in these.parameters have been
attributed to the Nurse Care Manager intervention as

these patients were receiving routine care prior to their
intervention. In addition, all participants have been

continuously enrolled in the Kaiser Health Plan for the

one-year preceding this study thus allowing direct
comparisons to take place from within as well as from
without this study population.
This data has been extracted from the Electronic

Health Record (FileMaker Pro 4.0() used by the Diabetes
Nurse Care Manager for recording all routine
interventions in the Preventive Medicine Department

including those interventions performed on the study
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population. The study group used a specific code for the
purpose of separate: identification. However, no Care
Manager was instructed to give either better or worse
care to this group.. The Standard of Care was to be the

same degree of excellence given all our patients. This
also allowed direct comparisons to take place from, within
as well as from without this, study population. ,
Other sources of data, include, the POINT Care

Management System, the legacy demographic; and laboratory

databases, as well as the Diabetes Outcome Reports.from

the Southern California Permanente Medical Group. The

data was analyzed with. Excel( functions and analysis
tools as well as,;,with Stat

Package for the Social

Sciences( (SPSS)., These also formed the basis for the

charts and graphs used within this study.

„

Data Analysis

,,

In order to demonstrate statistically significant

changes at baseline in Hemoglobih Ale frequency, ,Urinary
Microalbumin frequency, LDL-Cholesterol frequency/as
well as, changes in HbAlc values; w,e report simple means

or proportions, with, P-values from an unadjusted mixed
model analysis to compare the control and intervention
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groups. To control for the patient's expected likelihood
of receiving the routine cafe and screening tests, these

patients are being compared to their own pfevious lab
values, prior to the Care Management intefventiop.
Additional: data was collected on the frequency .of , 

performing yearly Diabetic Retinal: Screening
Examinations. This data was -compared to regional averages
within the - Kaiser-Permanente Health Ca.re system as well ,

as to national averages for. -other health care plans. That
data is avaiiable thfpugh the National Committee for . .
Quality Assurance website (HEDIS, 2000)".. .
-Data on the . presence of abnormal Urinary) ; ■

Microalbumin and abnormal ,LDL-Cholesterol were:, bbtained \
through.the POINT Care Management tool. This data tool
also prdvidad.infofmation on whether: each: patient,had;

received pha.rmaceutic.aT treatmen.t fof.^h.isVo^f^^^^ her clinical
, laboratofy . abnormality:.' That' data was also compared with .

other Kaiser fegions outside, of Southern California by
the 'Use pf the same .statistical .methods h

Results

■

There were, a total, of ,91 participants in. the study
that attended the :two-hour session with the 'Diabetes
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Nurse Care Manager and their Primary Care Physician. This

population consisted of 46 males and 45 females. There
were 55 participants from the High Desert Medical Office
in Victorville and 36 participants from the Colton

Medical Offices. Their average age was 56.2 + 11.2 years.
The range was from 33 to 84 years of age. No participants
were lost due to mortality. When examined for the
co-morbidities of Congestive Heart Failure, Renal
Disease, or Coronary Artery Disease; there were fourteen

(14) participants with one co-morbidity, three (3)
participants with two co-morbidities, and one (1)

participant with three co-morbidities.
Table 1 shows the outcomes of the care intervention

at three and six months. The average Hemoglobin Ale at

baseline was 10.34 + 1.33%. This illustrates the poor
control of the target population. The average Hemoglobin

Ale at three months post intervention was 8.34 + 1.61%.
This illustrates an improvement from the baseline value

in the short term. The average Hemoglobin Ale at six
months post intervention was 8.09 + 1.52%. This value
illustrates improvement from the baseline in the longer
term.
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For illustrating compliance/adherence the frequency

of performing a Hemoglobin Ale during the study period
was evaluated. This value was 86.81% compared with a
Southern California Regional average of 81.25% during a
similar period. Similar data from the National Committee
for Quality Assurance (HEDIS 2000) shows that Health
Plans from across the United States averaged 75.07 +
11.50%. Although this figure appears better than the

regional comparison figure, no statement can be made
about significance in the above cases.

The frequency of Retinal Screening Examinations,
Urinary Microalbumin, measurements, and LDL-Cholesterol
measurements illustrates the surrogate measures of

Quality of Care for this population. These.are the same
measures used by national Quality Assurance organizations

for ranking Managed.Care Organizations. The frequency of
Retinal Screening Examinations within a one-year period
was 81.32% for the study group. The national data from

the HEDIS data set of NCQA gives a value of 45.30 +
15.00%. The frequency of Urinary Microalbumin screening
was 93.41% for the study group and 36.08 + 14.38%,for the
HEDIS data set of NCQA. The frequency of LDL-Cholesterol
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Screening was 96;.:70% for the sttidy group and 69.09

,

:11.15%; for the HEbiS data set of :NCQi\.;
Table ,2 .illustrates the.:.changes in .glucose control

of the. study group during the thrpe and..six month . . ■
follow-up periods in this ihterventi.on. The. bar graphs
are skewed; to the left;, (oorre.spbnding'to poor control) in

the baseline (pre-intervehtipnl;;chart due,to the nature 

of the study model t.hat pre-selected ., for poorly ;

.

controlled at-risk diabetics with a HbAlc of 8.9% and

,

above in order to qualify for this study. The subsequent
three-month and six-month post intervention bar graphs

illustrate the profound change between the statistical
qua.rtiies .for ..Poor, -Fair., Good, , and Excellent glucose
control .occurring over time.
Tables 3, . 4, and. 5 focus upon the intent to treat
section, of the- study. There were 85 study .participants

that performed a Urinar-y Microalbumin. within a one-year..
■period around the study dates .: .0^^

number, there , were

44 Confirmed positive Microalbumin measurements and 41
confirmed negative .measuremehts, ■88.63% of. the positive
group received appropriate treatment for their.
Microalbumin. .Southern California Regional values for
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Microalbumin treatment are 77.vSS + 2.18% in an unselected

diabetic population.

There were 88 study participants that performed an 1
LDL-Cholestexol measurement-within a one-year period

around the , study dates .. Of this number, 62 were confirmed-

positive for abnormal.LDL-Cholesterol using the. Regional

Guideline of > 130 mg/dl.. ; 72.58% of the .positivelgfoup ■
received appropriate treatment for their Choles.terol ,

abnormality. This compares with 77.59 + 8.39% in an.

unselected diabetic population in the Southern California
Region..

Theve were 7'4 study pafticipants .that pe.rfornied a
Screening Retinal Examination within a one-year period,
around the . study dates. These studies were reviewed by an
Ophthalmologist to determine the course of treatment..

81.32% of the study population received this evaluation.
National statistics . from the HEDIS data set of NC.QA gives
a comparison of 45.30.+ 15.00% in an unselected national
diabetic population.
The above data appears to support the hypothesis,
that the introduction of the Diabetes Nurse Care Managers

into the Outlying Medical Offices has had a positive
effect on the. care delivered to an at-risk diabetic

in

population selected for poor glucose control. These
finding will impact the decision to continue and to
increase the use of this model of care within our

healthcare system.

CHAPTER FOUR

CONCLUSIONS AND RECOMMENDATIONS

Conclusions

Analyses of effective models of care for diabetes
and other chronic diseases suggest that the design of

practice plays an important role in their success. The
design of the practice refers to the delegation of roles
within the practice team, the involvement of other

disciplines, the organization of visits and follow-up,
and the integration of psychoeducational interventions.
Efforts to redesign primary care to improve outcomes in
diabetes have varied widely in approach. The
interventions include increased involvement of

nonphysician providers (usually nurses or nurse

practitioners), or changing the design of visits or the
handling of follow-up. An early approach was the

establishment of a periodic mini-clinic in primary care
as described in the British Studies.
We chose to test the effectiveness of chronic care

clinics (mini-clinics) with relatively unselected primary

care practices and diabetic patients in an HMO, as

opposed to limiting the intervention to volunteer
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practices and highly motivated patients, in an attempt to
assess its practicality and effectiveness as a system

change strategy. Because potential study patients were
selected at random, not by virtue of their interest in

participating, we had to make compromises.in the
completeness of the baseline data to assure high rates of
participation.
The intention-to-treat analysis findings suggest

that participation in Diabetes Nurse Care Manager clinics
resulted in improved processes of care and somewhat
better health. All measures of the process of diabetes

care were better in the intervention group than in the

control group, and many reached statistical significance
Whereas chronic care clinics, as described by

Wagner, Austin, and Von Korff (1996), relied on existing
clinic personnel to deliver services. Diabetes Care

Management nurse played an important role in the present

study that must he considered when estimating the full
cost of the intervention. A Diabetes Care Management

nurse handled most of the Group Appointment clinic
organizational tasks, i.e., scheduling time, space, and
patients; organizing patient assessments and treatment

planning; and planning the group session. Our initial
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plan was to have the study staff gradually turn most of
these responsibilities over to practice staff, but this
training takes time and resources that were unavailable
at that time. Ultimately, several practices took on these

responsibilities. We suspect that the impact of
mini-clinics on clinical and health outcomes would have

been much greater if practice nurses had sufficient time
and training to provide clinical case management as

described in the work of the British Physicians. This may

explain the modest effects of chronic care clinics on
HbAlc and other health status indicators.

This study provides evidence that relatively
unselected primary care practices can he reorganized to
provide better care for patients with chronic illnesses
in a system with other enhancements, such as registries

and guidelines. A related model, the cooperative health
care clinic (31), has been shown to improve outcomes in

diabetic patients (32). The diabetes cooperative health
care clinics differed from the chronic care clinics in

that they were led by a diabetes nurse educator, they did
not involve the primary care team, and they conducted
most of their assessment, education, and other activities

in a group setting (32). Bringing groups of chronically

ill patients into special primary care sessions designed
to meet their clinical, educational, and psychosocial

needs appears to he a feasible and effective way of
improving their care.
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APPENDIX

TABLES
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A

Table 1. Outcomes ofCare intervention at Baseline,3 Months,and 6 Months
Average Age(years)

56.2 + 11.2

Age Range(years)

33-84

Male/ Female

46/45

Comorbidities
1

14

2

3

3

1

Ave. HbAic(PreIntervention)

10.34+1.33

Ave. HbAic(3 Months)

8.34+1.61

Ave. HbAic(6 Months)

8.09 + 1.52

# Having at least 1 HbAic

79(86.81%) ,

# Having at least 2 HbAic

27(27.67%)

# With Eye Exam W/l 1 Year 74(81.31%)
# With Urine MA W/l 1 Year

85(93.41%)

#With LDL-Chol W/l 1 Year

88(96.70%)

Table 2. Change in Glucose Control During the Study
Period.

100
1

80

PreIntervention

60
40 X
y

1

X'

20

X

0
Poor

Fair

Good

Excellent

Glucose Control

25

20

15

3 Months

■

Intervention

■

10

Poor

Fair

Good

Excellent

Glucose Control

12

■

6 Months

Intervention

Poor

Fair

Good

Glucose Control

85

Excellent

Table 3. Treatment of Abnormal MIcroalbumIn

N = 85 Having Urinary MA Performed within 1 Year
Control Group

Study Group
39 Treated

(88.63%) and (11.36%)

44 Measured

77.35 + 2.78% Southern California Region

Not Treated

Table 4. Treatment of Abnormal LDL-Cholesterol.

N = 88 Having LDL-Cholesterol Performed within 1 Year.
77 + If using LDL Cutoff > 100 mg/dl
62 + If using LDL Cutoff > 130 mg/dl

Control Group

Study Group
47 Treated (61.03%) and (39.97%)
77 Measured

None Available

Not Treated

Control Group

Study Group

45 Treated (72.58%) and (27.42%)
Measured

62

77.59 +8.39% Southern California Region

Not Treated

Table 5. Frequency of Retinal Eye Examination and Evaluation.
N = 74 Having Eye Screening and Evaluation within one Year.
Study Group
74 Evaluated (81.31%)and (18.68%)

91 Population

Not Treated

Control Group
44.1 + 7.48% Southern California Region

APPENDIX

B

EXHIBITS

87

Exhibit 1. Business and Professions Code,Section 2725. Nursing Practice Act.
Article 2. Scope of Regulation
2725. Legislative Declaration; Practice ofNursing; Functions

(a)~In amending this section at the 1973\N74 session,the Legislature recognizes that
nursing is a dynamic field,the practice ofwhich is continually evolving to include
more sophisticated patient care activities,it is the intent ofthe Legislature in
amending this section at the 1973\N74 session to provide clear legal authority for
functions and procedures that have comrnon acceptance and usage.It is the legislative

intent also to recognize the existence ofoverlapping functions between physicians and
registered nurses and to permit additional sharing offunctions within organized health
care systems that provide for collaboration between physicians and registered nurses.
These organized health care systems include, but are not limited to, health facilities
licensed pursuant to Chapter 2(commencing with Section 1250)ofDivision 2ofthe
Health and Safety Code,clinics,home health agencies, physicians' offices, and public
or community health services.

(b)~The practice ofnursing within the meaning ofthis chapter means those functions,
including basic health care,that help people cope with difficulties in daily living that
are associated with their actual or potential health or illness problems or the treatment
thereof,and that require a substantial amount ofscientific Iqiowledge or technical
skill,including all ofthe following:
(1)~Direct and indirect patient care services that ensure the safety,comfort,personal

hygiene,and protection ofpatients; and the performance ofdisease prevention and
restorative measures.

r

(2)~Direct and indirect patient care services,including, but not limited to,the
administration ofmedications and therapeutic agents, necessary to implement a
treatment,disease prevention,or rehabilitative regimen ordered by and within the
scope oflicensme ofa physician,dentist, podiatrist,or clinical psychologist,as
defined by Section 1316.5 ofthe Health and Safety Code.
(3)~The performance ofskin tests,immunization techniques,and the withdrawal of
human blood from veins and arteries.

(4)~Observation ofsigns and symptoms ofillness,reactions to treatment, general
behavior,or general physical condition,and(A)determination ofwhether the signs,

symptoms,reactions, behavior,or general appearance exhibit abnormal characteristics,
and(B)implementation,based on observed abnormalities,ofappropriate reporting,or
referral, or standardized procedures,or changes in treatment regimen in accordance
with standardized procedures,or the initiation ofemergency procedures.

(c)~"Standardized procedures," as used in this section^ means either ofthe following:
(l)~Policies and protocols developed by a health facility licensed pursuant to Chapter

2(commencing with Section 1250)ofDivision 2ofthe Health and Safety Code
through collaboration among administrators and health professionals including
physicians and nurses.
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(2)~Policies and protocols developed through collaboration among administrators and
health professionals,including physicians and nurses, by an organized health care
system which is not a health facility licensed pursuant to Chapter 2(commencing with
Section 1250)ofDivision 2ofthe Health and Safety Code.
The policies and protocols shall be subject to any guidelines for standardized
procedures that the Division ofLicensing ofthe Medical Board ofCalifornia and the
Board ofRegistered Nursing mayjointly promulgate.Ifpromulgated,the guidelines
shall be administered by the Board ofRegistered Nursing.
(d)~Nothing in this section shall be construed to require approval ofstandardized
procedures by the Division ofLicensing ofthe Medical Board ofCalifornia,or by the
Board ofRegistered Nursing.
(Amended by Stats. 1995,c. 279(AB 1471),§ 15; Stats. 1996,c. 124(AB 3470),§ 2.)

2725.1. Dispensing Drugs or Devices; Registered Nurses; Limitations
Notwithstanding any other provision oflaw,a registered nurse may dispense drugs or
devices upon an order by a licensed physician and surgeon when the nurse is
functioning within a licensed clinic as defined in paragraphs(1)and(2)ofsubdivision
(a)ofSection 1204 of,or within a clinic as defined in subdivision(b)or(c)ofSection
1206,ofthe Health and Safety Code.
No clinic shall employ a registered nurse to perform dispensing duties exclusively. No
registered nurse shall dispense drugs in a pharmacy,keep a pharmacy,open shop,or
drugstore for the retailing ofdrugs or poisons. No registered nurse shall compound
drugs. Dispensing ofdrugs by a registered nurse,except a nurse practitioner who
functions pursuant to a standardized procedure described in Section 2836.1,or
protocol, shall not include substances included in the California Uniform Controlled
Substances Act(Division 10(commencing with Section 11000)ofthe Health and
Safety Code).Nothing in this section shall exempt a clinic from the provisions of

Article 3.5(commencing with Section 4063)ofChapter 9.
(Amended by Stats. 1999,c. 83(SB 966),§ 3; Stats. 1999,c.914(AB 1545),§ 1.)
2725.3. Health Facility; Use ofUnlicensed Personnel in Lieu ofRegistered Nurse;
Authorized Acts

(a)~A health facility licensed pursuant to subdivision(a),(b),or(f), ofSection 1250
ofthe Health and Safety Code shall not assign unlicensed personnel to perform
nursing functions in lieu ofa registered nurse and may not allow unlicensed personnel

to perform functions under the direct clinical supervision ofa registered nurse that
require a substantial amount ofscientific knowledge and technical skills,including,
but not limited to,any ofthe following:
(1)~Administration ofmedication.
(2)—Venipuncture or intravenous therapy.
(3)~Parenteral or tube feedings.
(4)~Invasive procedures including inserting nasogastric tubes,inserting catheters, or
tracheal suctioning.
(5)—Assessment ofpatient condition.
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(6)~Educating patients and their families concerning the patient\'s health care
problems,including postdischarge care.
(7)~Moderate complexity laboratory tests.
(b)~This section shall not preclude any person from performing any act or function
that he or she is authorized to perform pursuant to Division 2(commencing with
Section 500)or pursuant to existing statute or regulation as ofJuly 1, 1999.
(Added by Stats. 1999,c.945(AB 394),§ 2.)
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Exhibit 2. Raw data Prior to Analysis.
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